Cationic bovine serum albumin (CBA) conjugated poly lactic-co-glycolic acid (PLGA) nanoparticles for extended delivery of methotrexate into brain tumors-Reference-Cited by-同舟云学术

Cationic bovine serum albumin (CBA) conjugated poly lactic-co-glycolic acid (PLGA) nanoparticles for extended delivery of methotrexate into brain tumors

Published:2016 Issue:92 Volume:6 Page:89040-89050
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Kesharwani Prashant¹²³⁴⁵,Jain Ashay⁶⁷⁸⁹,Jain Atul⁶⁷⁸⁹,Jain Amit K.⁶⁷⁸⁹,Garg Neeraj Kumar⁶⁷⁸⁹,Tekade Rakesh Kumar¹⁰¹¹⁹,Raj Singh Thakur Raghu²¹²¹³¹⁴¹⁵,Iyer Arun K.¹⁶⁶¹⁷¹⁸¹⁹

Affiliation:

1. The International Medical University

2. School of Pharmacy

3. Department of Pharmaceutical Technology

4. Kuala Lumpur

5. Malaysia

6. Department of Pharmaceutical Sciences

7. Dr Hari Singh Gour University

8. Sagar

9. India

10. National Institute of Pharmaceutical Education and Research (NIPER)

11. Ahmedabad-380054

12. Queen's University Belfast

13. Medical Biology Centre

14. Belfast BT9 7BL

15. UK

16. Use-inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory

17. Eugene Applebaum College of Pharmacy and Health Sciences

18. Wayne State University

19. Detroit

Abstract

Current strategies for the treatment of brain tumors have been hindered primarily by the presence of the highly lipophilic, insurmountable blood–brain barrier (BBB).

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA17290C

Reference56 articles.

1. Brain cancer diagnosis and therapy with nanoplatforms☆

2. Dendrimer-mediated approaches for the treatment of brain tumor

3. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent

4. The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?

5. The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles;European Polymer Journal;2024-11

2. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy;Journal of Drug Targeting;2024-05-03

3. Emerging therapeutic landscape on delivery of oxytocin to brain for treating neurological disorders;Journal of Drug Delivery Science and Technology;2024-02

4. Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: A review;Results in Chemistry;2024-01

5. Recent Advances in Delivery of Peptide and Protein Therapeutics to the Brain;Journal of Pharmacology and Experimental Therapeutics;2023-11-17